Table 1. Main clinical and biologic characteristics of the 12 patients who had received solid organ transplants and 20 control patients in a study of a Pneumocystis jirovecii pneumonia outbreak at a university hospital in France, 2009–2015*.

Patient	Age, y/sex	Date of diagnosis	Underlying condition	Time since transplant, mo	Sample type	Fungal load, MSG copies/mL	Outcome
T1	34/F	2014 May 20	Pulmonary transplant	60	BAL	1.1 × 109	Died
T2	59/F	2014 May 27	Heart and kidney transplant	300 (H) – 2 (K)	BAL	3.9 × 108	Survived
T3	57/F	2014 Jun 19	Heart transplant	137	BAL	2.7 × 108	Died
T4	65/M	2014 Jul 7	Heart transplant	37	BAL	1.5 × 108	Died
T5	66/M	2014 Aug 19	Kidney transplant	4	Sputum	6.6 × 1010	Survived
T6	48/M	2014 Aug 29	Heart transplant	78	BAL	1 × 106	Survived
T7	74/F	2014 Oct 29	Kidney transplant	128	BAL	2 × 107	Died
T8	69/F	2014 Nov 24	Kidney transplant	23	BAL	8.8 × 106	Survived
T9	63/M	2015 Jan 7	Liver transplant	5	BAL	1.1 × 104	Survived
T10	69/M	2015 Jan 10	Kidney transplant	228	Sputum	1.2 × 105	Survived
T11	61/F	2015 Mar 3	Heart transplant	122	BAL	3.1 × 103	Survived
T12	75/F	2015 Aug 26	Heart transplant	95	BAL	2 × 105	Survived
C1	56/M	2012 Aug 25	Liver transplant	6	BA	6 × 106	Died (HCV relapse)
C2	52/M	2013 May 17	Pulmonary transplant	21	BAL	1.7 × 105	Survived
C3	82/F	2012 Mar 9	Rheumatoid polyarthritis	–	BAL	5.6 × 103	Survived
C4	62/M	2013 Aug 29	NHL	–	BAL	4.3 × 108	Survived
C5	66/M	2013 Sep 10	NHL	–	BAL	1.2 × 106	Survived
C6	25/M	2014 Feb 27	HIV	–	BAL	4.2 × 108	Survived
C7	1/F	2014 Apr 9	Primary immunodeficiency	–	BAL	5.2 × 109	Survived
C8	56/M	2014 Apr 19	HIV	–	BAL	4.3 × 109	Survived
C9	47/F	2014 Apr 24	Allografted AML with GVHD	–	BAL	1.4 × 106	Survived
C10	74/M	2014 Jul 1	NHL	–	BAL	6.1 × 108	Survived
C11	77/M	2014 Sep 4	MPN and NHL	–	BAL	1.2 × 105	Survived
C12	82/M	2014 Sep 5	NHL	–	BAL	5.8 × 104	Survived
C13	68/M	2014 Oct 10	Glioblastoma	–	BAL	3.4 × 1010	Survived
C14	7 mo/F	2014 Oct 15	Primary immunodeficiency	–	Sputum	4.7 × 106	Survived
C15	75/F	2014 Oct 23	B-chronic lymphoid leukemia	–	BAL	3.4 × 105	Survived
C16	82/F	2014 Dec 5	B-chronic lymphoid leukemia	–	BAL	1.1 × 104	Survived
C17	32/F	2015 Feb 27	Hodgkin's disease	–	BAL	1.2 × 104	Survived
C18	50/M	2015 Feb 28	Hodgkin's disease	–	BAL	6.4 × 103	Survived
C19	78/M	2015 Mar 18	B-chronic lymphoid leukemia	–	BAL	5.9 × 106	Survived
C20	75/M	2015 Mar 22	NHL	–	BA	3.9 × 104	Died
*T1–T12 indicate the 12 solid organ transplant patients from the cluster; C1–C20 indicate the 20 control patients. AML, acute myeloid leukemia; BA, bronchoaspiration; BAL, bronchoalveolar lavage fluids; GVHD, graft-versus-host disease; H, heart; K, kidney; MPN, myeloproliferative neoplasm; MSG, major surface glycoprotein; NA, not applicable; ND, not done; NHL, non-Hodgkin lymphoma; –, nonexistent or unspecified.